Hjem › Type 1-diabetes › Washington
Type 1-diabetes kliniske forsøg i Washington
20 studier for Type 1-diabetes søger deltagere på steder i Washington.
Byer i Washington
Officiel studietekst (engelsk)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
RekruttererObservationsstudie
Alder 8 til 35 · Alle køn · Opdateret 18. sep. 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RekruttererFase 2
Alder 18 til 69 · Alle køn · Opdateret 15. sep. 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
RekruttererFase 3
Alder 1 til 25 · Alle køn · Opdateret 14. sep. 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
RekruttererFase 1/2
Alder 12 til 35 · Alle køn · Opdateret 11. sep. 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
RekruttererFase 2
Alder 4 til 34 · Alle køn · Opdateret 9. sep. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
RekruttererFase 2
Alder 8 til 45 · Alle køn · Opdateret 8. sep. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
RekruttererFase 1/2
Alder 9 til 20 · Alle køn · Opdateret 2. sep. 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
RekruttererFase 2
Alder 5 til 40 · Alle køn · Opdateret 24. aug. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 16. jul. 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. jun. 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. apr. 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 9. apr. 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
RekruttererFase 2
Alder 18 til 50 · Alle køn · Opdateret 6. apr. 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 24. mar. 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RekruttererFase 3
Alder 18 til 49 · Alle køn · Opdateret 4. mar. 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Rekrutterer
Alder 16 til 19 · Alle køn · Opdateret 30. dec. 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
RekruttererObservationsstudie
Op til 70 år · Alle køn · Opdateret 19. dec. 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Rekrutterer
Alder 12 og opefter · Alle køn · Opdateret 16. dec. 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 2 til 45 · Alle køn · Opdateret 1. jul. 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
RekruttererFase 1
Alder 12 til 25 · Alle køn · Opdateret 13. jun. 2025 · NCT05065372Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.